A. Maity, “Clinical characteristics and outcomes of rivaroxaban 2.5 mg in chronic coronary syndrome: insights from the RICCS India study”, Int J Res Med Sci, vol. 13, no. 11, pp. 4671–4675, Oct. 2025.